CRS Newsletter Author Guidelines

Scope and Content
The Controlled Release Society Newsletter is a publication of the Controlled Release Society, a not-for-profit organization, whose sole aim is the promotion of the pharmaceutical sciences. The Newsletter is published 6 times a year. The Newsletter accepts unsolicited topical and concise articles which are of broad interest to scientists working in the area of drug delivery. There are four main categories into which these unsolicited/invited articles may fall: Spotlight, Scientifically Speaking, Special Features, and People in the News.

Spotlight
Spotlight articles are concise and informative articles which give an overview of the activities of pharmaceutical organizations working in the commercial sector. The article must not exceed 1000 words in length and must contain the following information:

  1. Brief company history (founders, company age, company vision)
  2. Science behind the company's vision or products (scientific background is very important)
  3. Examples of how the technology can make a contribution to human health, vet health, etc
  4. Any details on products for sale or non-confidential information on pipeline products
  5. Good quality color illustrations which depict key concepts, processes, and products associated with the company
  6. A maximum of five key references which offer the reader a deeper insight into the science behind the company

There is always intense competition for this section of the Newsletter, and authors are encouraged to maximize their chances of being selected for publication by producing concise, informative, and well illustrated pieces, which emphasize the translation of good science into viable commercial opportunities.

Scientifically Speaking
Scientifically Speaking articles are concise and informative articles detailing the science behind techniques, technological advances, or commercial products, which are of relevance to drug delivery. The article must not exceed 1000 words and must contain the following information:

  1. A description of the science underpinning the technology, techniques, and product emphasizing the novelty
  2. An overview of any perceived advantages over competing methods or systems
  3. Details of the applications of the technology, techniques, and products
  4. Examples, if available, of commercial products within which the technology and techniques have been incorporated or non-confidential examples of products under development.
  5. High quality color images which depict key concepts associated with the techniques, technological advances, and products
  6. A maximum of five key references which allow the reader to gain a deeper insight into the subject matter

Special Features
These opinion pieces are concise and informative articles which detail subjects which are thought to be of broad interest to the readership. The articles must not exceed 1000 words in length, and the scope and content of these articles are determined by the author. However, the article must contain a maximum of five key references which allow the readership to gain a deeper insight into the subject matter.

People in the News
People in the News articles detail extraordinary achievements of members of the Controlled Release Society or other scientists working in the area of drug delivery. The Newsletter is especially keen to feature members who have won international and national prizes as a result of their scientific achievements and contributions. These articles will be re-written in an in-house style; however, persons wishing to be featured in this section of the Newsletter must supply the following information.

  1. Name of prize winner
  2. Date of birth of prize winner
  3. Brief details of the prize won
  4. Brief biographical details of the prize winner which summarize the key scientific achievements
  5. A photograph of the prize winner to accompany the piece
  6. An indication of whether the prize winner would wish to be interviewed for the piece

Referencing Style

  1. Journal article - Matriano, JA, Cormier, M, Johnson, J, Young, WA, Buttery, M, Nyam, K, Daddona, PE. Macroflux-microprojection array patch technology: a new and efficient approach for intracutaneous immunization, Pharm. Res. 19: 63 - 66 (2001).
  2. Book - Florence, AT, Attwood, D. Physicochemical Principles of Pharmacy, Macmillan Press, Basingstoke (1998).
  3. Book Section - Bicknell, KA, Brooks, G. Methods of delivering DNA to target tissues and cells, In, Brooks, G, (ed.), Gene Therapy, Pharmaceutical Press, London, pp23-49.
  4. Patent - Tomalia, DA, Baker, JR, Bielinska, AU, Fazio, MJ, Hedstrand, DM, Kaplan, DA, Kruper, WJ, Kukowska-Latallo, J, Maxon, BD, Piehler, LT, Tomlinson, IA, Wilson LR, Yin, R, Brothers, HM, Bioactive and/ or targeted dendrimer conjugates, US5,714,166 (1998).
  5. Web page - Matthews, AW, FDA issues rules for personalized medicines, http://biz.yahoo.com/djus/031103/
    0020000014_1.html
    (2003).

Submission of Articles
Articles submitted for publication in the Controlled Release Society Newsletter must be sent as an email attachment to CRSNewsletter@scisoc.org. Submission is not a guarantee of publication. All content is subject to editorial review, acceptance, copy editing, and space allotment. Every effort will be made to return submissions that do not comply with the Author Guidelines to the author for possible resubmission at a later date.

Authors must indicate in their email into which category the article falls. Articles must be prepared using Microsoft Word®. All graphic images must be submitted as separate graphic files in either jpeg or tiff file format at 300 dpi. The deadline for submission of articles for the next issue of the Newsletter may be found at http://www.controlledreleasesociety.org/publications/Newletter.

Submitted articles must include and be written as follows:

  1. A proposed title
  2. Author's name as desired in the publication byline
  3. A signed Publication Release and Copyright Assignment
  4. Author's telephone number, facsimile number, and email address
  5. All text must be written in the third person
  6. Avoid abbreviations, if at all possible
  7. Common abbreviations may be acceptable in a long article but must be spelled out immediately followed by the abbreviation in parentheses the first time it is used
  8. Lists, bullet points, and subheadings should be avoided
  9. Long lists of names, materials, telephone numbers, etc., do not meet the criteria of a news article and will be edited

Last updated February 2011

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link